Related Experiment Video
Updated: Aug 16, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
[Tau-pathies: neurodegenerative diseases with pathology involving tau protein]
Anna Pokryszko-Dragan1, Mieszko M Zagrajek, Krzysztof Słotwiński
1Klinika Neurologii Akademii Medycznej we Wrocławiu, 50-420 Wrocław. A-Z@pharmanet.com.pl
Abstract:
Microtubule-associated protein tau (MAP-tau) plays an important role in stabilizing neuronal structure, in axonal transport, regulating cellular division, and apoptotic processes. In recent years the structure and functions of MAP-tau, as well as its physiological changes and pathology, have been extensively studied. Degenerative diseases of the central nervous system having MAP-tau involved in their pathogenesis are called tau-pathies. This group includes Alzheimer's disease, frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration. The authors present the clinical pictures of these diseases (with the dominant features of dementia), and current possibilities in their diagnosis and treatment. MAP-tau as a marker for neurodegenerative process is already used in the diagnosis of tau-pathies. Further studies on its pathology may also give rise to some new therapeutic strategies.
More Related Videos
12:55Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
12:47Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins
Published on: December 27, 2016
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Parkinson Disease ll: Pathophysiology
Dementia l: Introduction
Parkinson's Disease: Overview
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...